TAT-LP-PTX

General Information


DRACP ID  DRACP05621

Peptide Name   TAT-LP-PTX

Sequence  CAYGRKKRRQRRR

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Protein derived

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Cysteine addition

C-terminal Modification  Rhodamine LP

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C70H128N34O16S

Absent amino acids  DEFHILMNPSTVW

Common amino acids  R

Mass  194827

Pl  12.51

Basic residues  8

Acidic residues  0

Hydrophobic residues  1

Net charge  8

Boman Index  -10227

Hydrophobicity  -274.62

Aliphatic Index  7.69

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25482610

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2517

DRACP is developed by Dr.Zheng's team.